AKER Akers Biosciences Inc gains 21% Nov 5, 2021

Akers Biosciences, Inc. focuses on the development of a vaccine candidate against SARS-CoV-2, a coronavirus causing a pandemic. It has a collaboration agreement with Premas Biotech PVT Ltd. The company was founded in 1989 and is headquartered in Thorofare, New Jersey.http://www.priceseries.com/trade/AKER-Akers-Biosciences-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2021101120211105.html

Posted by : priceSeries Monday, November 08, 2021

Subscribe by Email

Follow Updates Articles from This Blog via Email